US Patent Issued to Beijing Gene MINK Biotechnology on Sept. 23 for "Method for efficiently infecting human natural killer cells and other immune cells with pseudovirus" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,955, issued on Sept. 23, was assigned to Beijing Gene MINK Biotechnology Co.LTD (Beijing).

"Method for efficiently infecting human natural killer cells and other immune cells with pseudovirus" was invented by Yongfeng Liu (Beijing) and Zhihua Lu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure belongs to the field of biotechnology, and specifically relates to a method for efficiently infecting human natural killer (NK) cells and other immune cells with a pseudovirus. Specifically, a viral transfection system provided in the present disclosure has an envelope plasmid with a protein having an X-Y-Z structure. The X is an...